Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
TEAM heads into its October 29 earnings with analysts raising targets in unison, short sellers retreating, and an index addition probability hanging over the stock.
The analyst bid is the clearest signal this week. Three firms lifted targets inside the past three days alone: Wells Fargo raised its Overweight target to $230 from $180, Barclays moved to $222 from $172, and RBC Capital pushed to $235 from $215. The direction of travel across the wider analyst community has been uniformly upward since early August, with BofA, Citigroup, and Baird all lifting targets as well. The mean Street target now sits at $211, close to the current price of $208, which leaves limited formal upside by consensus math. But the pace of target increases, most moving $30 to $50 in a single revision, tells a different story about conviction.
Short positioning reinforces the bullish lean. Short interest has fallen sharply over the past month, dropping about 21% in shares to 5.2% of free float. Over the past week alone shorts gave up another 6.3%. The borrow market reflects that retreat: cost to borrow has slipped to 0.36% annually, down 9% on the week, and availability is extraordinarily loose at roughly 8,870% of short interest. That figure, meaning there are roughly 89 shares available for every one already borrowed, points to no meaningful squeeze mechanics and little appetite among short sellers to rebuild positions at current levels. Options confirm the absence of fear, with the put/call ratio at 0.76, barely above its 20-day average and well below the 52-week high of 1.43.
The bull-bear debate ahead of the print centres on Atlassian's AI monetisation against a mechanical revenue headwind. Bulls cite Subscription ARR of $6.6 billion at the end of FY2026, up 23% year on year, with customers using Rovo expanding ARR at roughly twice the rate of non-adopters and completing 20% more Jira work items. The Teamwork Graph, tracking over 200 billion objects and relationships, strengthens the AI efficiency argument. Bears flag the Data Center end-of-life pull-forward that distorted FY2026 reported growth, with total revenue guided to grow only around 13% in FY2027 and Data Center revenue expected to fall roughly 17% year on year. R&D near 50% of revenue and a dual-class structure concentrating about 86% of voting power with co-founders Michael Cannon-Brookes and Scott Farquhar, who each hold around 18.7% of shares, are secondary concerns the bears carry. Valuation is not cheap: price-to-book of 14.8x and a PE of 32.2x leave little margin for a guide-down.
One structural overlay worth noting is Atlassian's candidacy for the Nasdaq-100. ORTEX puts the probability of inclusion in the December 2026 Annual Review at 44%, with the stock currently sitting 1.6% above the entry price line at $204.64. At a current market cap of $52.7 billion, Atlassian qualifies today. An inclusion would require index trackers to buy an estimated $2.9 billion of stock, equivalent to roughly 3.5 days of normal volume. The announcement date is pencilled for December 11 with an effective date of December 21, though these are estimated until the index provider confirms. In the 14 comparable past additions, the median move from announcement to effective was plus 2.1%, with 79% moving the expected way and trade-day volume running at 4.5 times normal. That history describes what happened before, not what happens this time, and the probability is still shy of a coin flip.
GQG Partners filed a 13G/A in August disclosing it had reduced its stake from 8.42% to 4.8% with shares owned reported as zero at last filing, a notable exit from a position built earlier in the year. Baillie Gifford similarly cut its disclosed stake from 5.0% to 2.3%. On the other side, BlackRock added 1.2 million shares to reach 5.0% as of September 30, and AQR Capital Management built a fresh 5.53% position disclosed in August. All 13D/G stakes are event-driven disclosures around the 5% threshold and may not reflect current holdings.
With earnings 15 days away, the setup to watch is whether the Street's target-raise momentum reflects genuine conviction about the first FY2027 quarter, or whether the absence of short sellers and a possible index-buying tailwind are doing more of the price work than the fundamentals.
See the live data behind this article on ORTEX.
Open TEAM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
